Novel vaccine strategy demonstrates potential for Alzheimer's disease

被引:1
|
作者
Hillery, A
机构
来源
关键词
D O I
10.1016/S1461-5347(99)00193-5
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
To summarize this editorial, I would suggest that the tools for system integration and data and information are now available from several external companies in most domains of the industry. It is also possible to purchase the basic cools and build your own. However, the ability to integrate information is not sufficient to maximize the potential value of all the information generated. In addition, the maximum value of the information generated within the industry currently resides in the heads of the individuals. This is not. in my opinion, the most satisfactory situation. Other industries have already faced this situation and are applying new IT technology to build corporate knowledge bares rather than corporate databases. It is up to the individual companies, IT departments and computer literate groups to go our and assess the potential value of this new technology with an open mind. The most important position for such new technology is at the interface between discovery and development, because at this step large quantities of data and information are available; any decision relies on the appropriate interpretation of a complex matrix of properties. An inappropriate interpretation at this stage can result in significant cost to the organization.
引用
收藏
页码:347 / 348
页数:2
相关论文
共 50 条
  • [41] TREM2: A Novel Potential Biomarker of Alzheimer's Disease
    Zhang, Xiao Min
    Liu, Jing
    Cao, Min
    Yang, Ting Ting
    Wang, Ya Qi
    Hou, Yu Li
    Song, Qiao
    Cui, Yu Ting
    Wang, Pei Chang
    [J]. BIOMEDICAL AND ENVIRONMENTAL SCIENCES, 2021, 34 (09) : 719 - 724
  • [42] Assessment of Novel Rexinoids for Therapeutic Potential in Combating Alzheimer's Disease
    Pedroza, Morgan
    Mallick, Sanchita
    Marshall, Pamella
    Wagner, Carl
    Jurutka, Peter
    [J]. FASEB JOURNAL, 2020, 34
  • [43] TREM2: A Novel Potential Biomarker of Alzheimer's Disease
    ZHANG Xiao Min
    LIU Jing
    CAO Min
    YANG Ting Ting
    WANG Ya Qi
    HOU Yu Li
    SONG Qiao
    CUI Yu Ting
    WANG Pei Chang
    [J]. Biomedical and Environmental Sciences, 2021, (09) : 719 - 724
  • [44] The role of caspases in Alzheimer's disease; potential novel therapeutic opportunities
    Rohn, Troy T.
    [J]. APOPTOSIS, 2010, 15 (11) : 1403 - 1409
  • [45] Novel Tacrine Analogs as Potential Cholinesterase Inhibitors in Alzheimer's Disease
    El-Malah, Afaf
    Gedawy, Ehab M.
    Kassab, Asmaa E.
    Salam, Rania M. Abdel
    [J]. ARCHIV DER PHARMAZIE, 2014, 347 (02) : 96 - 103
  • [46] The role of caspases in Alzheimer’s disease; potential novel therapeutic opportunities
    Troy T. Rohn
    [J]. Apoptosis, 2010, 15 : 1403 - 1409
  • [47] Novel Indole Derivatives as Potential Imaging Agents for Alzheimer's Disease
    Yu, Lihai
    Scheunemann, Matthias
    Deuther-Conrad, Winnie
    Hiller, Achim
    Fischer, Steffen
    Sorger, Dietlind
    Sabri, Osama
    Jia, Hongmei
    Steinbach, Joerg
    Brust, Peter
    Liu, Boli
    [J]. BULLETIN OF THE KOREAN CHEMICAL SOCIETY, 2010, 31 (01) : 177 - 180
  • [48] Cucumber mosaic virus as the expression system for a potential vaccine against Alzheimer's disease
    Vitti, A.
    Piazzolla, G.
    Condelli, V.
    Nuzzaci, M.
    Lanorte, M. T.
    Boscia, D.
    De Stradis, A.
    Antonaci, S.
    Piazzolla, P.
    Tortorella, C.
    [J]. JOURNAL OF VIROLOGICAL METHODS, 2010, 169 (02) : 332 - 340
  • [49] Multitarget Cannabinoids as Novel Strategy for Alzheimer Disease
    Gonzalez-Naranjo, Pedro
    Campillo, Nuria E.
    Perez, Concepcion
    Paez, Juan A.
    [J]. CURRENT ALZHEIMER RESEARCH, 2013, 10 (03) : 229 - 239
  • [50] Triple GLP-1/GIP/glucagon receptor agonists, a potential novel treatment strategy in Alzheimer's disease
    Camins, Antoni
    Ettcheto, Miren
    Busquets, Oriol
    Manzine, Patricia R.
    Dario Castro-Torres, Ruben
    Beas-Zarate, Carlos
    Verdaguer, Ester
    Sureda, Francesc X.
    Bullo, Monica
    Olloquequi, Jordi
    Auladell, Carme
    Folch, Jaume
    [J]. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2019, 28 (01) : 93 - 97